Related Experiment Videos

Mitochondria in platinum resistant cells

S Isonishi1, M Saitou, M Yasuda

  • 1Department of Obstetrics/Gynecology, Jikei University School of Medicine.

Human Cell
|January 5, 2002
PubMed

Insights

Mitochondrial alterations enhance platinum resistance in cancer cells by altering mitochondrial membrane potential and reducing apoptosis. This suggests targeting mitochondria could overcome drug resistance.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Cancer Research

Background:

  • Mitochondrial (MT) alterations are linked to platinum (Pt) drug resistance.
  • Understanding the role of alternative MT function in Pt cytotoxicity and apoptosis is crucial.

Purpose of the Study:

  • To investigate the involvement of mitochondrial function in platinum resistance.
  • To determine the relationship between mitochondrial alterations and apoptosis in Pt-resistant cancer cells.

Main Methods:

  • Assessed mitochondrial membrane potential (delta psi m) using rhodamine 123 (Rh).
  • Utilized laser confocal microscopy and electron microscopy to examine mitochondrial morphology and distribution.
  • Performed Western blot analysis for Bcl-2 and Cytochrome C (CytC) expression.

Main Results:

  • Pt-resistant cells exhibited elevated MT membrane potential and altered MT distribution.
  • Pt-resistant cells showed increased Bcl-2 overexpression and retained Cytochrome C within mitochondria.
  • Pt-sensitive cells displayed Cytochrome C release from mitochondria upon cisplatin treatment.

Conclusions:

  • Mitochondrial alterations significantly impact cancer cell resistance to platinum-induced apoptosis.
  • Changes in mitochondrial function, including membrane potential and Cytochrome C regulation, are key factors in developing Pt resistance.

Related Concept Videos